Flash Memory

Showing 220 articles
Business

Galenica's Five-Year Surge: A 90% Return for Patient Investors

Swiss healthcare group Galenica has delivered robust returns for long-term shareholders, with a total return of 90% over five years, significantly outpacing the broader market. While recent performance has moderated, the stock's journey highlights the value of consistent earnings growth and dividends.

Business

Itron's Meteoric Rise: How the Utility Tech Firm Outpaced the Market with 71% Gains

While index funds offer market-average returns, picking the right stock can yield significantly more. Itron, Inc. (NASDAQ: ITRI) has proven just that, delivering a 71% return to shareholders over the past three years—outperforming broader indices—as it transitioned to profitability. However, recent headwinds have tempered the rally, raising questions about its near-term trajectory.